-
1
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
-
DOI 10.1016/S0140-6736(02)08512-4
-
Hanauer SB, Feagan BG, Lichtenstein GR, et al.: Maintenance infliximab for Crohn's disease: the ACCENT 1 randomised trial. Lancet 2002; 359:1541-1549. (Pubitemid 34621118)
-
(2002)
Lancet
, vol.359
, Issue.9317
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
Rachmilewitz, D.7
Wolf, D.C.8
Olson, A.9
Bao, W.10
Rutgeerts, P.11
-
2
-
-
33646147141
-
Serious Infections and Mortality in Association with Therapies for Crohn's disease: TREAT Registry
-
Lichtenstein GR, Feagan BG, Cohen RD, et al.: Serious Infections and Mortality in Association With Therapies for Crohn's disease: TREAT Registry. Clin Gastroentrol Hepatol 2006; 4:621-630.
-
(2006)
Clin Gastroentrol Hepatol
, vol.4
, pp. 621-630
-
-
Lichtenstein, G.R.1
Feagan, B.G.2
Cohen, R.D.3
-
3
-
-
58649121974
-
Infliximab prevents Crohn's disease recurrence after ileal resection
-
Regueiro M, Schraut W, Baidoo L, et al.: Infliximab prevents Crohn's disease recurrence after ileal resection Gastroenterology 2009; 136:441-450.
-
(2009)
Gastroenterology
, vol.136
, pp. 441-450
-
-
Regueiro, M.1
Schraut, W.2
Baidoo, L.3
-
4
-
-
33750133513
-
Interleukin-12 and Th1 immune response in Crohn's disease: Pathogenetic relevance and therapeutic inplication
-
Peluso I, Pallone F, Monteleone G: Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 2006; 12:5606-5610. (Pubitemid 44594033)
-
(2006)
World Journal of Gastroenterology
, vol.12
, Issue.35
, pp. 5606-5610
-
-
Peluso, I.1
Pallone, F.2
Monteleone, G.3
-
5
-
-
33646417072
-
The IL-23/IL-17 axis in inflammation
-
Iwakura Y, Ishigame H: The IL-23/IL-17 axis in inflammation. J Clin Invest 2006; 116:1218-1222.
-
(2006)
J Clin Invest
, vol.116
, pp. 1218-1222
-
-
Iwakura, Y.1
Ishigame, H.2
-
6
-
-
53049091561
-
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
-
Sandborn WJ, Feagan BG, Fedorak RM: A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology 2008; 135:1130-1141.
-
(2008)
Gastroenterology
, vol.135
, pp. 1130-1141
-
-
Sandborn, W.J.1
Feagan, B.G.2
Fedorak, R.M.3
-
8
-
-
0036096689
-
Infliximab: An updated review of its use in Crohn's disease and rheumatoid arthritis
-
Keating GM, Perry CM: Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. BioDrugs 2002; 16:111-48. (Pubitemid 34533773)
-
(2002)
BioDrugs
, vol.16
, Issue.2
, pp. 111-148
-
-
Keating, G.M.1
Perry, C.M.2
-
9
-
-
32044474228
-
TNF-α blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: A novel anti-inflammatory mechanism of infliximab in Crohn's disease
-
Danese S, Sans M, Scaldaferri F, et al.: TNF-α blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol 2006; 176:2617-2624. (Pubitemid 43201714)
-
(2006)
Journal of Immunology
, vol.176
, Issue.4
, pp. 2617-2624
-
-
Danese, S.1
Sans, M.2
Scaldaferri, F.3
Sgambato, A.4
Rutella, S.5
Cittadini, A.6
Pique, J.M.7
Panes, J.8
Katz, J.A.9
Gasbarrini, A.10
Fiocchi, C.11
-
10
-
-
33749262823
-
Infliximab reduces the number of activated mucosal lymphocytes in patients with Crohn's disease
-
Ferkolj I, Ihan A, Markovic S, et al.: Infliximab reduces the number of activated mucosal lymphocytes in patients with Crohn's disease. J Gastrointestin Liver Dis 2006; 15:231-235. (Pubitemid 44483090)
-
(2006)
Journal of Gastrointestinal and Liver Diseases
, vol.15
, Issue.3
, pp. 231-235
-
-
Ferkolj, I.1
Ihan, A.2
Markovic, S.3
Veceric, Z.4
Pohar, M.5
-
11
-
-
0029671297
-
In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects
-
Lorenz HM, Antoni C, Valerius T, et al.: In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol 1996; 156; 1646-1653.
-
(1996)
J Immunol
, vol.156
, pp. 1646-1653
-
-
Lorenz, H.M.1
Antoni, C.2
Valerius, T.3
-
12
-
-
34249085886
-
Crohn's disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue?
-
Minderhoud IM, Samsom M, Oldenburg B: Crohn's disease, fatigue, and infliximab: is there a role for cytokines in the pathogenesis of fatigue? World J Gastroenterol 2007; 13:2089-93. (Pubitemid 46795847)
-
(2007)
World Journal of Gastroenterology
, vol.13
, Issue.14
, pp. 2089-2093
-
-
Minderhoud, I.M.1
Samsom, M.2
Oldenburg, B.3
-
13
-
-
20144383986
-
Profile of soluble cytokine receptors in Crohn's disease
-
DOI 10.1136/gut.2004.043554
-
Gustot T, Lemmers A, Nicaise C, et al.: Profile of soluble cytokine receptors in Crohn's disease. Gut 2005; 54:488-495. (Pubitemid 40395500)
-
(2005)
Gut
, vol.54
, Issue.4
, pp. 488-495
-
-
Gustot, T.1
Lemmers, A.2
Louis, E.3
Nicaise, C.4
Quertinmont, E.5
Belaiche, J.6
Roland, S.7
Van Gossum, A.8
Deviere, J.9
Franchimont, D.10
-
14
-
-
37249013895
-
Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity
-
DOI 10.1007/s10620-007-9849-6
-
Nancey S, Hamzaoui N, Moussata D, et al.: Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity. Dig Dis Sci 2008; 53:242-247. (Pubitemid 350265676)
-
(2008)
Digestive Diseases and Sciences
, vol.53
, Issue.1
, pp. 242-247
-
-
Nancey, S.1
Hamzaoui, N.2
Moussata, D.3
Graber, I.4
Bienvenu, J.5
Flourie, B.6
-
15
-
-
0037043658
-
Inflammatory bowel disease
-
Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002; 347:417-429.
-
(2002)
N Engl J Med
, vol.347
, pp. 417-429
-
-
Podolsky, D.K.1
-
16
-
-
0037022008
-
Crohn's disease
-
Shanahan F: Crohn's disease. Lancet 2002; 359:62-69.
-
(2002)
Lancet
, vol.359
, pp. 62-69
-
-
Shanahan, F.1
-
17
-
-
0347510684
-
The mucosal immune system
-
MacDonald TT: The mucosal immune system. Parasite Immunol 2003; 25:235-246.
-
(2003)
Parasite Immunol
, vol.25
, pp. 235-246
-
-
MacDonald, T.T.1
-
18
-
-
18344410191
-
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
-
DOI 10.1038/75068
-
Atreya R, Mudter J, Finotto S, et al.: Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nat Med 2000; 6:583-588. (Pubitemid 30305911)
-
(2000)
Nature Medicine
, vol.6
, Issue.5
, pp. 583-588
-
-
Atreya, R.1
Mudter, J.2
Finotto, S.3
Mullberg, J.4
Jostock, T.5
Wirtz, S.6
Schutz, M.7
Bartsch, B.8
Holtmann, M.9
Becker, C.10
Strand, D.11
Czaja, J.12
Schlaak, J.F.13
Lehr, H.A.14
Autschbach, F.15
Schurmann, G.16
Nishimoto, N.17
Yoshizaki, K.18
Ito, H.19
Kishimoto, T.20
Galle, P.R.21
Rose-John, S.22
Neurath, M.F.23
more..
-
19
-
-
0036624721
-
Interleukin-7: From bench to clinic
-
DOI 10.1182/blood.V99.11.3892
-
Fry TJ, Mackall CL: Interleukin-7: from bench to clinic. Blood 2002; 99:3892-3904. (Pubitemid 35332024)
-
(2002)
Blood
, vol.99
, Issue.11
, pp. 3892-3904
-
-
Fry, T.J.1
Mackall, C.L.2
-
20
-
-
0029074399
-
Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes
-
Watanabe M, Ueno Y, Yaji T: Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 1995; 95:2945-2953.
-
(1995)
J Clin Invest
, vol.95
, pp. 2945-2953
-
-
Watanabe, M.1
Ueno, Y.2
Yaji, T.3
-
21
-
-
0030067724
-
Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease
-
Daig R, Andus T: Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996; 38:216-222.
-
(1996)
Gut
, vol.38
, pp. 216-222
-
-
Daig, R.1
Andus, T.2
-
22
-
-
0024339229
-
Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8
-
Mukaida N, Shiroo M, Matsushima K: Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989; 143:1366-1371. (Pubitemid 19211374)
-
(1989)
Journal of Immunology
, vol.143
, Issue.4
, pp. 1366-1371
-
-
Mukaida, N.1
Shiroo, M.2
Matsushima, K.3
-
23
-
-
0027582292
-
Neutrophil activating peptide in colonic mucosa from patients with Crohn's disease
-
Izzo RS, Witkon K, Chien AI, et al.: Neutrophil activating peptide in colonic mucosa from patients with Crohn's disease. Scand J Gastroenterol 1993; 28:296-300.
-
(1993)
Scand J Gastroenterol
, vol.28
, pp. 296-300
-
-
Izzo, R.S.1
Witkon, K.2
Chien, A.I.3
-
24
-
-
0028319023
-
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease
-
Mitsuyama K, Toyunaga A, Sasaki E, et al.: IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994; 96:432-436. (Pubitemid 24224862)
-
(1994)
Clinical and Experimental Immunology
, vol.96
, Issue.3
, pp. 432-436
-
-
Mitsuyama, K.1
Toyonaga, A.2
Sasaki, E.3
Watanabe, K.4
Tateishi, H.5
Nishiyama, T.6
Saiki, T.7
Ikeda, H.8
Tsuruta, G.9
Tanikawa, K.10
-
25
-
-
0030862103
-
Intestinal interleukin 8 concentration and gene expression in inflammatory bowel disease
-
Nielsen OH, Rudiger N, Gaustadnes M, et al.: Intestinal interleukin 8 concentration and gene expression in inflammatory bowel disease. Scand J Gastroenterol 1997; 32:1028-1032.
-
(1997)
Scand J Gastroenterol
, vol.32
, pp. 1028-1032
-
-
Nielsen, O.H.1
Rudiger, N.2
Gaustadnes, M.3
-
26
-
-
0037313578
-
Interleukin-12 and the regulation of innate resistance and adaptive immunity
-
Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3:133-146.
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 133-146
-
-
Trinchieri, G.1
-
27
-
-
34247523141
-
Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation
-
DOI 10.1146/annurev.immunol.22.012703.104758
-
Kastelein RA, Hunter CA, Cua DJ: Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25:221-242. (Pubitemid 46697908)
-
(2007)
Annual Review of Immunology
, vol.25
, pp. 221-242
-
-
Kastelein, R.A.1
Hunter, C.A.2
Cua, D.J.3
-
28
-
-
66149156478
-
Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut
-
Caruso R, Sarra M, Stolfi C, et al.: Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 2009; 136:2270-2279.
-
(2009)
Gastroenterology
, vol.136
, pp. 2270-2279
-
-
Caruso, R.1
Sarra, M.2
Stolfi, C.3
-
29
-
-
33750133513
-
Interleukin-12 and Th1 immune response in Crohn's disease: Pathogenetic relevance and therapeutic inplication
-
Peluso I, Pallone F, Monteleone G: Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 2006; 12:5606-5610. (Pubitemid 44594033)
-
(2006)
World Journal of Gastroenterology
, vol.12
, Issue.35
, pp. 5606-5610
-
-
Peluso, I.1
Pallone, F.2
Monteleone, G.3
-
30
-
-
0001885778
-
Chemokines in IBD mucosa: Expression of RANTES, MIP-1α, MIPI-1βand interferon inducible protein 10 by macrophages, lymphocytes, endothelial cells and granulomas
-
Grimm MC, Doe WF: Chemokines in IBD mucosa: expression of RANTES, MIP-1α, MIPI-1βand interferon inducible protein 10 by macrophages, lymphocytes, endothelial cells and granulomas. Inflammatory Bowel Dis 1996; 2:88-96.
-
(1996)
Inflammatory Bowel Dis
, vol.2
, pp. 88-96
-
-
Grimm, M.C.1
Doe, W.F.2
-
31
-
-
0037220898
-
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease
-
DOI 10.1002/path.1245
-
Banks C, Bateman A, Payne R, et al.: Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathology 2003; 199:28-35. (Pubitemid 36054726)
-
(2003)
Journal of Pathology
, vol.199
, Issue.1
, pp. 28-35
-
-
Banks, C.1
Bateman, A.2
Payne, R.3
Johnson, P.4
Sheron, N.5
|